Lexicon Pharmaceuticals
LXRX
LXRX
109 hedge funds and large institutions have $662M invested in Lexicon Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 29 increasing their positions, 34 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
15% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 34
47% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 19
67% less call options, than puts
Call options by funds: $939K | Put options by funds: $2.87M
Holders
109
Holding in Top 10
2
Calls
$939K
Puts
$2.87M
Top Buyers
| 1 | +$9.31M | |
| 2 | +$2.01M | |
| 3 | +$1.45M | |
| 4 |
First Manhattan
New York
|
+$1.27M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$1.15M |
Top Sellers
| 1 | -$5.6M | |
| 2 | -$2.09M | |
| 3 | -$1.07M | |
| 4 |
AIM
Assured Investment Management
New York
|
-$611K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$598K |